Abstract Details
|
Daniel Wallman, MD
(Boston Medical Center)
PRESENTER |
No disclosure on file |
| Anna D. Hohler, MD, FÂ鶹´«Ã½Ó³» (Steward SEMC) | Dr. Hohler has nothing to disclose. |
| Joseph F. Quinn, MD, FÂ鶹´«Ã½Ó³» (OHSU Neurology) | Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| No disclosure on file | |
| Zetta M. Fayos, MD (Washington University) | No disclosure on file |